A review of preanalytical factors affecting molecular, protein, and morphological analysis of formalin-fixed, paraffin-embedded (FFPE) tissue: how well do you know …

BP Bass, KB Engel, SR Greytak… - Archives of pathology …, 2014 - meridian.allenpress.com
Context Formalin fixation and paraffin embedding is a timeless, cost-efficient, and widely
adopted method of preserving human tissue biospecimens that has resulted in a substantial …

Tissue microarray technology for high-throughput molecular profiling of cancer

OP Kallioniemi, U Wagner, J Kononen… - Human molecular …, 2001 - academic.oup.com
Tissue microarray (TMA) technology allows rapid visualization of molecular targets in
thousands of tissue specimens at a time, either at the DNA, RNA or protein level. The …

Origin, methods, and evolution of the three Nurses' Health Studies

Y Bao, ML Bertoia, EB Lenart… - … journal of public …, 2016 - ajph.aphapublications.org
We have summarized the evolution of the Nurses' Health Study (NHS), a prospective cohort
study of 121 700 married registered nurses launched in 1976; NHS II, which began in 1989 …

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

M Dowsett, TO Nielsen, R A'Hern… - Journal of the …, 2011 - academic.oup.com
Uncontrolled proliferation is a hallmark of cancer. In breast cancer, immunohistochemical
assessment of the proportion of cells staining for the nuclear antigen Ki67 has become the …

Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer

SMA Mahmoud, EC Paish, DG Powe… - Journal of clinical …, 2011 - ascopubs.org
Breast carcinomas are often infiltrated by inflammatory cells, particularly macrophages and T
lymphocytes, but the significance of these cells remains unclear. One possible role of these …

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

MCU Cheang, SK Chia, D Voduc, D Gao… - JNCI: Journal of the …, 2009 - academic.oup.com
Background Gene expression profiling of breast cancer has identified two biologically
distinct estrogen receptor (ER)-positive subtypes of breast cancer: luminal A and luminal B …

X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization

RL Camp, M Dolled-Filhart, DL Rimm - Clinical cancer research, 2004 - aacrjournals.org
The ability to parse tumors into subsets based on biomarker expression has many clinical
applications; however, there is no global way to visualize the best cut-points for creating …

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

CG Kleer, Q Cao, S Varambally, R Shen, I Ota… - Proceedings of the …, 2003 - pnas.org
The Polycomb Group Protein EZH2 is a transcriptional repressor involved in controlling
cellular memory and has been linked to aggressive prostate cancer. Here we investigate the …

Prognostic markers in triple‐negative breast cancer

EA Rakha, ME El‐Sayed, AR Green, AHS Lee… - Cancer, 2007 - Wiley Online Library
BACKGROUND. Triple‐negative breast cancer (estrogen receptor‐negative, progesterone
receptor‐negative, and HER2‐negative) is a high risk breast cancer that lacks the benefit of …

Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring

AE Rizzardi, AT Johnson, RI Vogel, SE Pambuccian… - Diagnostic …, 2012 - Springer
Abstract Immunohistochemical (IHC) assays performed on formalin-fixed paraffin-embedded
(FFPE) tissue sections traditionally have been semi-quantified by pathologist visual scoring …